Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2025 Filed Jan 7, 2025 00:00 UTC |
DUNBAR GEORGE W JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,750 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001415889-25-000869 · form4-01062025_070107.xml · derivative · entry 3 DUNBAR GEORGE W JR · CIK 0001194712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,750 Underlying: Common Stock · 5,750 shares Expires 2035-01-02 F3 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board service. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:00 UTC |
DUNBAR GEORGE W JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 3,600 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001415889-25-000869 · form4-01062025_070107.xml · derivative · entry 2 DUNBAR GEORGE W JR · CIK 0001194712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,600 Underlying: Common Stock · 3,600 shares Expires 2035-01-02 F2 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board committee service. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:00 UTC |
DUNBAR GEORGE W JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 11,940 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001415889-25-000869 · form4-01062025_070107.xml · derivative · entry 1 DUNBAR GEORGE W JR · CIK 0001194712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,940 Underlying: Common Stock · 11,940 shares Expires 2035-01-02 F1 · derivative.exercise_date: The shares vest 1/12th of the first day of each month, commencing February 1, 2025, with the last month vesting on December 31, 2025, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:00 UTC |
COLLIER EARL M JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,750 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001415889-25-000868 · form4-01062025_070105.xml · derivative · entry 3 COLLIER EARL M JR · CIK 0001201254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,750 Underlying: Common Stock · 5,750 shares Expires 2035-01-02 F3 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board service. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:00 UTC |
COLLIER EARL M JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 3,240 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001415889-25-000868 · form4-01062025_070105.xml · derivative · entry 2 COLLIER EARL M JR · CIK 0001201254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,240 Underlying: Common Stock · 3,240 shares Expires 2035-01-02 F2 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board committee service. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:00 UTC |
COLLIER EARL M JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 11,940 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001415889-25-000868 · form4-01062025_070105.xml · derivative · entry 1 COLLIER EARL M JR · CIK 0001201254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,940 Underlying: Common Stock · 11,940 shares Expires 2035-01-02 F1 · derivative.exercise_date: The shares vest 1/12th of the first day of each month, commencing February 1, 2025, with the last month vesting on December 31, 2025, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:00 UTC |
Gotwals Philip JDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,750 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001415889-25-000867 · form4-01062025_070102.xml · derivative · entry 3 Gotwals Philip J · CIK 0001982655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,750 Underlying: Common Stock · 5,750 shares Expires 2035-01-02 F3 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board service. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:00 UTC |
Gotwals Philip JDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,160 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001415889-25-000867 · form4-01062025_070102.xml · derivative · entry 2 Gotwals Philip J · CIK 0001982655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,160 Underlying: Common Stock · 2,160 shares Expires 2035-01-02 F2 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board committee service. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:00 UTC |
Gotwals Philip JDirector
|
GrantStock Option (Right to Buy) · Derivative | 11,940 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001415889-25-000867 · form4-01062025_070102.xml · derivative · entry 1 Gotwals Philip J · CIK 0001982655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,940 Underlying: Common Stock · 11,940 shares Expires 2035-01-02 F1 · derivative.exercise_date: The shares vest 1/12th of the first day of each month, commencing February 1, 2025, with the last month vesting on December 31, 2025, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| December 13, 2024 Filed Dec 16, 2024 14:25 UTC |
Krasney KarenEVP, GENERAL COUNSEL
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-24-029406 · form4-12162024_091201.xml · derivative · entry 3 Krasney Karen · CIK 0001593086 · EVP, GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2026-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: This option was granted on June 2, 2016 and was previously covering 50,000 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. F4 · derivative.exercise_date: Shares vested 1/48th on the first day of each month commencing July 1, 2016. F3 · derivative.underlying_shares: This option was granted on June 2, 2016 and was previously covering 50,000 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. Read SEC document |
| December 13, 2024 Filed Dec 16, 2024 14:25 UTC |
Krasney KarenEVP, GENERAL COUNSEL
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-24-029406 · form4-12162024_091201.xml · derivative · entry 2 Krasney Karen · CIK 0001593086 · EVP, GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2025-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: This option was granted on March 3, 2015 and was previously covering 30,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. F2 · derivative.exercise_date: Shares vested 1/48th on the first day of each month commencing April 1, 2015. F1 · derivative.underlying_shares: This option was granted on March 3, 2015 and was previously covering 30,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. Read SEC document |
| December 13, 2024 Filed Dec 16, 2024 14:25 UTC |
Krasney KarenEVP, GENERAL COUNSEL
|
Exercise / conversionCommon Stock | 8,000 | $1.39 | $11,120.00 |
DisclosureSEC source: 0001415889-24-029406 · form4-12162024_091201.xml · nonDerivative · entry 1 Krasney Karen · CIK 0001593086 · EVP, GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 01:00 UTC |
Litvack FrankDirector
|
Exercise / conversionWarrants (Right to Buy) · Derivative | 20,391 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0001415889-24-028337 · form4-12042024_081201.xml · derivative · entry 5 Litvack Frank · CIK 0001310715 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Family Trust Disclosed balance after: 0 Underlying: Common Stock · 20,391 shares Expires 2024-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Held by Litvack Curtis Family Trust for which the Reporting Person serves as trustee. Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 01:00 UTC |
Litvack FrankDirector
|
Exercise / conversionCommon Stock | 20,391 | $1.10 | $22,430.10 |
DisclosureSEC source: 0001415889-24-028337 · form4-12042024_081201.xml · nonDerivative · entry 1 Litvack Frank · CIK 0001310715 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held in Family Trust Disclosed balance after: 46,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Held by Litvack Curtis Family Trust for which the Reporting Person serves as trustee. Read SEC document |
| December 02, 2024 Filed Dec 5, 2024 01:00 UTC |
Litvack FrankDirector
|
GiftWarrants (Right to Buy) · Derivative | 20,391 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0001415889-24-028337 · form4-12042024_081201.xml · derivative · entry 4 Litvack Frank · CIK 0001310715 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Family Trust Disclosed balance after: 20,391 Underlying: Common Stock · 20,391 shares Expires 2024-12-17 F1 · ownership.nature: Held by Litvack Curtis Family Trust for which the Reporting Person serves as trustee. Read SEC document |
| December 02, 2024 Filed Dec 5, 2024 01:00 UTC |
Litvack FrankDirector
|
GiftWarrants (Right to Buy) · Derivative | 20,391 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0001415889-24-028337 · form4-12042024_081201.xml · derivative · entry 3 Litvack Frank · CIK 0001310715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,391 shares Expires 2024-12-17 Read SEC document |
| September 20, 2024 Filed Sep 24, 2024 20:01 UTC |
Nippon Shinyaku Co Ltd10% owner
|
PurchaseCommon Stock, par value $0.001 per share | 2,798,507 | $5.36 | $14,999,997.52 |
DisclosureSEC source: 0000929638-24-003214 · form4.xml · nonDerivative · entry 1 Nippon Shinyaku Co Ltd · CIK 0001361865 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,090,351 F1 · shares: On September 20, 2024, Capricor Therapeutics, Inc., a Delaware corporation (the "Issuer") issued 2,798,507 shares of common stock, $0.001 par value per share (the "Common Stock") to Nippon Shinyaku Co Ltd (the "Reporting Person"), acquired in a private placement pursuant to the terms and conditions of a Subscription Agreement, dated as of September 16, 2024, between the Reporting Person and the Issuer. Read SEC document |
| August 07, 2024 Filed Aug 9, 2024 13:00 UTC |
Musket David BDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 34,000 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-24-021022 · form4-08092024_090802.xml · derivative · entry 3 Musket David B · CIK 0001310611 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 34,000 shares Expires 2030-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares vested 1/48th of the first day of each month, commencing March 1, 2020. Read SEC document |
| August 07, 2024 Filed Aug 9, 2024 13:00 UTC |
Musket David BDirector
|
Exercise / conversionCommon Stock | 34,000 | $1.39 | $47,260.00 |
DisclosureSEC source: 0001415889-24-021022 · form4-08092024_090802.xml · nonDerivative · entry 1 Musket David B · CIK 0001310611 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 23, 2024 Filed Apr 24, 2024 17:30 UTC |
Musket David BDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,750 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-24-011416 · form4-04242024_010401.xml · derivative · entry 8 Musket David B · CIK 0001310611 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,750 shares Expires 2029-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: This option was granted on August 8, 2019 and was previously reported with an exercise price of $3.25 per share, but was adjusted to reflect a share reprice to $1.39 per share that occurred on February 12, 2020. F10 · derivative.exercise_date: The shares vested 1/48th of the first day of each month, commencing September 1, 2019. Read SEC document |
| April 23, 2024 Filed Apr 24, 2024 17:30 UTC |
Musket David BDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-24-011416 · form4-04242024_010401.xml · derivative · entry 7 Musket David B · CIK 0001310611 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2029-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: This option was granted on August 8, 2019 and was previously reported with an exercise price of $3.25 per share, but was adjusted to reflect a share reprice to $1.39 per share that occurred on February 12, 2020. Read SEC document |
| April 23, 2024 Filed Apr 24, 2024 17:30 UTC |
Musket David BDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,750 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-24-011416 · form4-04242024_010401.xml · derivative · entry 6 Musket David B · CIK 0001310611 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,750 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: This option was granted on January 2, 2018 and was previously reported as covering 27,500 shares at an exercise price of $1.57 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. F8 · derivative.exercise_date: The shares vested 1/12th of the first day of each month, commencing February 1, 2018 with the last 1/12th vesting on December 31, 2018. Read SEC document |
| April 23, 2024 Filed Apr 24, 2024 17:30 UTC |
Musket David BDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,050 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-24-011416 · form4-04242024_010401.xml · derivative · entry 5 Musket David B · CIK 0001310611 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,050 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: This option was granted on January 2, 2018 and was previously reported as covering 10,500 shares at an exercise price of $1.57 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. F6 · derivative.exercise_date: The shares vested 1/48th of the first day of each month, commencing February 1, 2018. Read SEC document |
| April 23, 2024 Filed Apr 24, 2024 17:30 UTC |
Musket David BDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,750 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-24-011416 · form4-04242024_010401.xml · derivative · entry 4 Musket David B · CIK 0001310611 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,750 shares Expires 2027-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: This option was granted on January 3, 2017 and was previously reported as covering 27,500 shares at an exercise price of $2.55 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. F4 · derivative.exercise_date: The shares vested 1/12th of the first day of each month, commencing February 1, 2017 with the last 1/12th vesting on December 31, 2017. Read SEC document |
| April 23, 2024 Filed Apr 24, 2024 17:30 UTC |
Musket David BDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 856 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-24-011416 · form4-04242024_010401.xml · derivative · entry 3 Musket David B · CIK 0001310611 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 856 shares Expires 2027-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: This option was granted on January 3, 2017 and was previously reported as covering 8,560 shares at an exercise price of $2.55 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. F2 · derivative.exercise_date: The shares vested 1/48th of the first day of each month, commencing February 1, 2017. F1 · derivative.underlying_shares: This option was granted on January 3, 2017 and was previously reported as covering 8,560 shares at an exercise price of $2.55 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. Read SEC document |
| April 23, 2024 Filed Apr 24, 2024 17:30 UTC |
Musket David BDirector
|
Exercise / conversionCommon Stock | 16,156 | $1.39 | $22,456.84 |
DisclosureSEC source: 0001415889-24-011416 · form4-04242024_010401.xml · nonDerivative · entry 1 Musket David B · CIK 0001310611 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 23, 2024 Filed Apr 25, 2024 13:15 UTC |
COLLIER EARL M JRDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-24-011488 · form4-04252024_090402.xml · derivative · entry 2 COLLIER EARL M JR · CIK 0001201254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,000 Underlying: Common Stock · 30,000 shares Expires 2030-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares vested 1/48th of the first day of each month, commencing March 1, 2020. Read SEC document |
| April 23, 2024 Filed Apr 25, 2024 13:15 UTC |
COLLIER EARL M JRDirector
|
Exercise / conversionCommon Stock | 30,000 | $1.39 | $41,700.00 |
DisclosureSEC source: 0001415889-24-011488 · form4-04252024_090402.xml · nonDerivative · entry 1 COLLIER EARL M JR · CIK 0001201254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
Kelliher MikeDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000658 · form4-01042024_050133.xml · derivative · entry 4 Kelliher Mike · CIK 0001987188 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-01-02 F4 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of April 1, 2024. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
Kelliher MikeDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,730 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000658 · form4-01042024_050133.xml · derivative · entry 3 Kelliher Mike · CIK 0001987188 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,730 Underlying: Common Stock · 4,730 shares Expires 2034-01-02 F3 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board service. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
Kelliher MikeDirector
|
GrantStock Option (Right to Buy) · Derivative | 890 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000658 · form4-01042024_050133.xml · derivative · entry 2 Kelliher Mike · CIK 0001987188 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 890 Underlying: Common Stock · 890 shares Expires 2034-01-02 F2 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board committee service. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
Kelliher MikeDirector
|
GrantStock Option (Right to Buy) · Derivative | 29,250 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000658 · form4-01042024_050133.xml · derivative · entry 1 Kelliher Mike · CIK 0001987188 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,250 Underlying: Common Stock · 29,250 shares Expires 2034-01-02 F1 · derivative.exercise_date: The shares vest 1/12th of the first day of each month, commencing February 1, 2024, with the last month vesting on December 31, 2024, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
Gotwals Philip JDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,370 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000657 · form4-01042024_050126.xml · derivative · entry 3 Gotwals Philip J · CIK 0001982655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,370 Underlying: Common Stock · 6,370 shares Expires 2034-01-02 F3 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board service. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
Gotwals Philip JDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,330 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000657 · form4-01042024_050126.xml · derivative · entry 2 Gotwals Philip J · CIK 0001982655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,330 Underlying: Common Stock · 1,330 shares Expires 2034-01-02 F2 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board committee service. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
Gotwals Philip JDirector
|
GrantStock Option (Right to Buy) · Derivative | 29,250 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000657 · form4-01042024_050126.xml · derivative · entry 1 Gotwals Philip J · CIK 0001982655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,250 Underlying: Common Stock · 29,250 shares Expires 2034-01-02 F1 · derivative.exercise_date: The shares vest 1/12th of the first day of each month, commencing February 1, 2024, with the last month vesting on December 31, 2024, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
Auwaerter Paul GisbertDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,760 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000656 · form4-01042024_050118.xml · derivative · entry 3 Auwaerter Paul Gisbert · CIK 0001982730 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,760 Underlying: Common Stock · 6,760 shares Expires 2034-01-02 F3 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board service. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
Auwaerter Paul GisbertDirector
|
GrantStock Option (Right to Buy) · Derivative | 890 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000656 · form4-01042024_050118.xml · derivative · entry 2 Auwaerter Paul Gisbert · CIK 0001982730 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 890 Underlying: Common Stock · 890 shares Expires 2034-01-02 F2 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board committee service. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
Auwaerter Paul GisbertDirector
|
GrantStock Option (Right to Buy) · Derivative | 29,250 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000656 · form4-01042024_050118.xml · derivative · entry 1 Auwaerter Paul Gisbert · CIK 0001982730 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,250 Underlying: Common Stock · 29,250 shares Expires 2034-01-02 F1 · derivative.exercise_date: The shares vest 1/12th of the first day of each month, commencing February 1, 2024, with the last month vesting on December 31, 2024, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
Musket David BDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,280 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000654 · form4-01042024_050114.xml · derivative · entry 3 Musket David B · CIK 0001310611 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,280 Underlying: Common Stock · 14,280 shares Expires 2034-01-02 F3 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board service. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
Musket David BDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,170 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000654 · form4-01042024_050114.xml · derivative · entry 2 Musket David B · CIK 0001310611 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,170 Underlying: Common Stock · 15,170 shares Expires 2034-01-02 F2 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board committee service. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
Musket David BDirector
|
GrantStock Option (Right to Buy) · Derivative | 29,250 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000654 · form4-01042024_050114.xml · derivative · entry 1 Musket David B · CIK 0001310611 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,250 Underlying: Common Stock · 29,250 shares Expires 2034-01-02 F1 · derivative.exercise_date: The shares vest 1/12th of the first day of each month, commencing February 1, 2024, with the last month vesting on December 31, 2024, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
DUNBAR GEORGE W JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,280 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000653 · form4-01042024_050112.xml · derivative · entry 3 DUNBAR GEORGE W JR · CIK 0001194712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,280 Underlying: Common Stock · 14,280 shares Expires 2034-01-02 F3 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board service. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
DUNBAR GEORGE W JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,920 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000653 · form4-01042024_050112.xml · derivative · entry 2 DUNBAR GEORGE W JR · CIK 0001194712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,920 Underlying: Common Stock · 8,920 shares Expires 2034-01-02 F2 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board committee service. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
DUNBAR GEORGE W JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 29,250 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000653 · form4-01042024_050112.xml · derivative · entry 1 DUNBAR GEORGE W JR · CIK 0001194712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,250 Underlying: Common Stock · 29,250 shares Expires 2034-01-02 F1 · derivative.exercise_date: The shares vest 1/12th of the first day of each month, commencing February 1, 2024, with the last month vesting on December 31, 2024, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
Sabar Karimah EsDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,280 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000655 · form4-01042024_050116.xml · derivative · entry 3 Sabar Karimah Es · CIK 0001873796 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,280 Underlying: Common Stock · 14,280 shares Expires 2034-01-02 F3 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board service. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
Sabar Karimah EsDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,460 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000655 · form4-01042024_050116.xml · derivative · entry 2 Sabar Karimah Es · CIK 0001873796 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,460 Underlying: Common Stock · 4,460 shares Expires 2034-01-02 F2 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board committee service. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
Sabar Karimah EsDirector
|
GrantStock Option (Right to Buy) · Derivative | 29,250 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000655 · form4-01042024_050116.xml · derivative · entry 1 Sabar Karimah Es · CIK 0001873796 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,250 Underlying: Common Stock · 29,250 shares Expires 2034-01-02 F1 · derivative.exercise_date: The shares vest 1/12th of the first day of each month, commencing February 1, 2024, with the last month vesting on December 31, 2024, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
Litvack FrankDirector
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000651 · form4-01042024_050108.xml · derivative · entry 1 Litvack Frank · CIK 0001310715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2034-01-02 F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2024, until the stock option becomes fully vested and exercisable. The award pertains to annual board service as Executive Chairman. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
COLLIER EARL M JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,280 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000652 · form4-01042024_050110.xml · derivative · entry 3 COLLIER EARL M JR · CIK 0001201254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,280 Underlying: Common Stock · 14,280 shares Expires 2034-01-02 F3 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board service. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:15 UTC |
COLLIER EARL M JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,030 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001415889-24-000652 · form4-01042024_050110.xml · derivative · entry 2 COLLIER EARL M JR · CIK 0001201254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,030 Underlying: Common Stock · 8,030 shares Expires 2034-01-02 F2 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board committee service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.